tibsovo
FDA approves Agios’ oral leukaemia treatment Tibsovo
July 23, 2018Sales and Marketing FDA, agios, approval, pharmaceuticals, tibsovo
The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
